Krilogy Financial’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,131
| Closed | -$632K | – | 241 |
|
|
2023
Q1 | $632K | Buy |
3,131
+894
| +40% | +$180K | 0.05% | 232 |
|
|
2022
Q4 | $487K | Sell |
2,237
-607
| -21% | -$132K | 0.05% | 253 |
|
|
2022
Q3 | $560K | Buy |
2,844
+44
| +2% | +$8.66K | 0.07% | 188 |
|
|
2022
Q2 | $599K | Buy |
2,800
+264
| +10% | +$56.5K | 0.07% | 184 |
|
|
2022
Q1 | $720K | Sell |
2,536
-1,043
| -29% | -$296K | 0.07% | 160 |
|
|
2021
Q4 | $1.35M | Sell |
3,579
-33
| -0.9% | -$12.4K | 0.14% | 105 |
|
|
2021
Q3 | $1.49M | Sell |
3,612
-33
| -0.9% | -$13.6K | 0.15% | 98 |
|
|
2021
Q2 | $1.35M | Sell |
3,645
-123
| -3% | -$45.5K | 0.13% | 106 |
|
|
2021
Q1 | $1.09M | Buy |
3,768
+733
| +24% | +$212K | 0.12% | 115 |
|
|
2020
Q4 | $758K | Buy |
3,035
+114
| +4% | +$28.5K | 0.09% | 143 |
|
|
2020
Q3 | $661K | Buy |
+2,921
| New | +$661K | 0.09% | 138 |
|
|
2020
Q1 | – | Sell |
-4,799
| Closed | -$733K | – | 196 |
|
|
2019
Q4 | $733K | Buy |
4,799
+61
| +1% | +$9.32K | 0.12% | 101 |
|
|
2019
Q3 | $627K | Buy |
4,738
+753
| +19% | +$99.6K | 0.11% | 102 |
|
|
2019
Q2 | $565K | Buy |
3,985
+533
| +15% | +$75.6K | 0.11% | 102 |
|
|
2019
Q1 | $501K | Buy |
+3,452
| New | +$501K | 0.11% | 103 |
|